经口腔前庭入路内镜甲状腺切除术的安全性与结局
该回顾性研究纳入2014年4月至2016年8月泰国警察总医院接受经口腔前庭入路内镜甲状腺切除术(TOETVA)或开放甲状腺切除术(OT)的患者,经倾向评分匹配后比较两组结局。TOETVA组手术时间更长、疼痛评分更低,而出血量和并发症发生率与OT组无显著差异,且无永久性喉返神经麻痹或永久性甲状旁腺功能减退。
要点
- TOETVA手术时间较OT延长,但疼痛评分更低。
- TOETVA与OT的出血量和并发症发生率无显著差异。
- TOETVA无永久性喉返神经麻痹或永久性甲状旁腺功能减退。
核心结论
- TOETVA与OT安全性相当,仅需常规腹腔镜器械,避免切口瘢痕,可作为特定患者的选择。
研究设计与样本
- 回顾性研究,纳入2014年4月1日至2016年8月31日泰国警察总医院所有TOETVA和OT手术患者,排除既往颈部手术、胸骨后甲状腺肿、淋巴结或远处转移、怀疑侵犯邻近器官者,采用倾向评分匹配减少选择偏倚。
主要发现
- 425例TOETVA患者中422例成功完成,3例因出血中转开放;25例(5.9%)发生暂时性喉返神经麻痹,46例(10.9%)发生暂时性甲状旁腺功能减退,无永久性病例。
- 3例(0.7%)发生暂时性颏神经损伤,均在4个月内缓解;1例术后血肿需开放手术处理;20例(4.7%)血清肿经简单抽吸治疗。
- TOETVA组手术时间较OT组长(100.8±39.7 vs 79.4±32.1分钟,P=1.61×10^-10),疼痛视觉模拟评分较低(1.1±1.2 vs 2.8±1.2,P=2.52×10^-38)。
关键数值与推荐
- TOETVA组暂时性喉返神经麻痹发生率5.9%,暂时性甲状旁腺功能减退发生率10.9%,暂时性颏神经损伤发生率0.7%,血清肿发生率4.7%。
- TOETVA组手术时间100.8±39.7分钟,OT组79.4±32.1分钟,P=1.61×10^-10。
- TOETVA组疼痛视觉模拟评分1.1±1.2,OT组2.8±1.2,P=2.52×10^-38。
临床怎么用
- 对于适合的甲状腺手术患者,TOETVA可作为一种避免颈部瘢痕的选择,但需注意手术时间较长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Natural orifice transluminal endoscopic surgery thyroidectomy is a novel approach to avoid surgical scars. OBJECTIVE: To compare the safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach (TOETVA) with those of open thyroidectomy (OT). DESIGN, SETTING, AND PARTICIPANTS: This study retrospectively reviewed all TOETVA and OT operations performed from April 1, 2014, through August 31, 2016, at Police General Hospital, Bangkok, Thailand. All patients who underwent TOETVA and patients who underwent OT were included. Exclusion criteria were (1) previous neck surgery, (2) substernal goiter, (3) lymph node or distance metastasis, and (4) suspicious invasion to the adjacent organs. Propensity score matching was conducted to reduce selective bias. MAIN OUTCOMES AND MEASURES: Operative time, blood loss, and complications related to thyroid surgery. RESULTS: Of the 425 patients who underwent transoral endoscopic thyroidectomy (mean age, 35.3 [12.1] years; age range, 16-81 years; 389 [92.2%] female), 422 successfully were treated with the TOETVA; 3 patients were converted to a conventional operation because of bleeding. Twenty-five patients (5.9%) had transient recurrent laryngeal nerve palsy, and 46 (10.9%) had transient hypoparathyroidism. None had permanent recurrent laryngeal nerve palsy or permanent hypoparathyroidism. Three patients (0.7%) had transient mental nerve injury; all cases resolved by 4 months. One patient developed postoperative hematoma treated by OT. Twenty patients (4.7%) had seroma treated by simple aspiration. Operative time was longer for the TOETVA compared with the OT group (100.8 [39.7] vs 79.4 [32.1] minutes, P = 1.61 × 10-10). The mean (SD) visual analog scale score for pain was lower in the TOETVA group (1.1 [1.2] vs 2.8 [1.2], P = 2.52 × 10-38). Estimated mean (SD) blood loss (36.9 [32.4] vs 37.6 [23.1] mL, P = .43) and rate of complications (45 of 216 [20.8%] vs 38 of 216 [17.6%], P = .41) were not significantly different in the TOETVA vs OT group. CONCLUSIONS AND RELEVANCE: The TOETVA was performed as safely as OT, requires only conventional laparoscopic instruments, and avoids incisional scars; thus, the approach may be an option for select patients.
引用
- Anuwong A, Ketwong K, Jitpratoom P, et al. Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg. 2018. PMID: 28877292. doi:10.1001/jamasurg.2017.3366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。